Cancer News: Gastric

Similar outcomes for two treatments options for gastric cancer

Post-operative treatment intensification with chemoradiotherapy and post-operative chemotherapy induced similar outcomes to gastric cancer patients.

Palliative care helps families facing cancer

Palliative care showed to improve caregivers’ quality of life and mood creating a powerful positive feedback loop in families facing cancer.

Everolimus gets FDA approval for another indication

Everolimus got approved by the FDA for the treatment of inoperable, locally advanced or metastatic neuroendocrine tumors of gastrointestinal or lung origin.

Positive outcomes from immunotherapies in gastrointestinal cancers

Pembrolizumab and nivolumab, two targeted immunotherapies, appeared effective in advanced gastric and esophageal cancers, two trials revealed.

Everolimus to cover unmet health care need

The agent everolimus showed real promise in treating patients with nonfunctional neuroendocrine tumors of lung or gastrointestinal origin, a new study reveals.

Lynparza boosts gastric cancer overall survival

The combination of olaparib (Lynparza) and paclitaxel improved overall survival in high-risk gastric cancer patients, a new study revealed.

New drug for advanced stomach cancer approved in Europe

A new drug has been approved to treat advanced stomach cancer or gastro-esophageal junction adenocarcinoma, following prior chemotherapy, in Europe.

Stomach cancer patients benefit from surgery plus chemoradiation

Patients who receive radiation therapy, in addition to chemotherapy after surgery for stomach cancer appear to have better survival rates.

Gastroesophageal cancer tied to weight as a teen

Israelis who were overweight as teenagers were more likely to have esophageal or gastroesophageal junction cancers later in life, researchers reported.

Chemo agents equal in treating gastric cancer

Weekly paclitaxel was as effective as biweekly irinotecan (Camptosar) as second-line therapy for advanced gastric cancer, researchers found.

Early gastric cancer detection aided by sugars

Gastric cancer is quite treatable when diagnosed early, and researchers have taken a first step towards identifying sugars attached to proteins to help timely diagnosis.

Advanced stomach cancer experimental combination treatment prolongs survival

Advanced gastric cancer patients' survival was prolonged with a combination of an experimental angiogenesis inhibitor and chemotherapy, in a large trial.

Metastatic stomach cancer treatment combination improves outcomes

Combining standard 2nd-line chemotherapy with the targeted therapy ramucirumab improves survival, quality of life for patients with metastatic gastric cancer.

Does red and processed meat really increase cancer risk?

While recent reports warn about eating red and processed meat and its impact on cancer risk, a new paper authored by 23 scientists indicates uncertainties.

Stomach cancer may be detected earlier in the future

The latest research on stomach (gastric) cancer brings new hope for its early detection, thanks to the identification of four new biomarkers in patients’ blood.

Advanced stomach cancer drug approved by the FDA

The FDA has approved ramucirumab (an angiogenesis inhibitor, trade name: "Cyramza") for treatment of advanced gastric cancer or gastroesophageal adenocarcinoma.

Login to your account

Did you forget your password?